Complications of intravenous Streptokinase therapy in acute myocardial infarction patients admitted to the cardiac intensive care unit

Message:
Abstract:
Aim

The aim of this study was to evaluate complications of intravenous Streptokinase therapy in acute myocardial infarction patients admitted to the cardiac intensive care unit.

Background

Myocardial infarction is a common disease and the use of thrombolytic agents such as Streptokinase reduces its mortality، but there are some complications associated with streptokinase.

Method

In this descriptive stud y 120، patients treated with streptokinase were evaluated in terms of complications of the drug. A checklist of Streptokinase complications was used to collect the data. The findings were presented in the form of descriptive and inferential statistics.

Findings

According to the finding s، %33. 3 of patients had cardiovascular complications، %23. 9 developed allergic symptoms، and %17. 5 suffered blood complications.

Conclusion

The incidence of cardiac complications was the highest among patients. It is recommended to train nurses to avoid possible complications.

Language:
Persian
Published:
Cardiovascular Nursing Journal, Volume:1 Issue: 4, 2013
Pages:
14 to 20
magiran.com/p1236750  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!